An observational study in Blood Pressure, sponsored by AstraZeneca. Completed at 375 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-12-18.
Sponsored by AstraZeneca · Observational
Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.
6,689 studies on the registry are indexed under Hypertension; 964 are open to participants now.
This study's planned enrollment of 1,200 is above the median of 210 across 1,358 observational studies indexed under Hypertension.
Browse Hypertension studies →AstraZeneca is the lead sponsor of 3,429 studies on the registry; 270 are open to participants now.
Of its 357 completed or terminated interventional studies of FDA-regulated products, 173 (48%) have results posted.
Counted across the registry records on this site, refreshed daily.
First 2 consecutive adults with hypertension, without known cardio vascular or renal disease,seen by Cardiologists
Inclusion Criteria:
To evaluate the frequency of evaluation of target organs preclinical impairment on patients without known cardiovascular or renal disease, taking into consideration the blood pressure level (controlled HBP or not)
Time frame: Once
Showing the first 100 of 375 sites.
This study is completed, as verified in Dec 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
AstraZeneca